96740 ⎘
Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof; Linear peptides containing only normal peptide links having 12 to 20 amino acids
Sub-classes:REAGENTS AND METHODS FOR CELL IDENTIFICATION AND CHARACTERIZATION
#2COMPOSITIONS INCLUDING TUMOR-BINDING GMCSF FUSION PROTEINS AND METHODS OF USING THE SAME TO TREAT SOLID TUMORS
#3SYNTHETIC ANTIMICROBIAL PEPTIDES
#4BIOINFORMATIC PROCESSES FOR DETERMINATION OF PEPTIDE BINDING
#5Carrier Peptide Fragment and Use Thereof
#6BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR EPHA2
#7CHIMERIC PROTEIN COMPRISING AN ANTI-INFLUENZA VIRUS ANTIBODY MOIETY AND A MUCOADHESIVE PEPTIDE FRAGMENT FOR PREVENTING OR TREATING INFLUENZA INFECTIONS
#8INHIBITORS OF NFAT AND NFKB SIGNALING FOR IMPROVING IMMUNE CELL FUNCTION
#9SELF-ASSEMBLING PEPTIDE COMPOSITIONS
#10NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING NEURONAL AND BRAIN TUMORS
#11EPITOPE TAGS RECOGNIZED BY SPECIFIC BINDERS
#12EPITOPE TAGS RECOGNIZED BY SPECIFIC BINDERS
#13ACTIVATING AGENTS
#14COMPOSITIONS AND METHODS FOR TREATING ENDOMETRIOSIS
#15PEPTIDE AND ASSEMBLY OR COMPOSITION CONTAINING SAID PEPTIDE
#16ANTIMICROBIAL PEPTIDE HALYMORIN VARIANTS AND METHODS OF USING THE SAME
#17SELF-ASSEMBLING PEPTIDE GEL FORMULATION AND METHODS OF USE
#18CELL-PENETRATING PEPTIDES
#19INHIBITORS FOR PROTEIN N-TERMINAL METHYLTRANSFERASE AND USES THEREOF
#20MELANOCORTIN RECEPTOR LIGANDS
#21PROTEOGLYCAN MIMETICS FOR ENHANCED WOUND HEALING, ANGIOGENESIS, AND VASCULAR REPAIR
#22INHIBITORS FOR PROTEIN N-TERMINAL METHYLTRANSFERASE AND USES THEREOF
#23EPHA2 TARGETING AGENTS AND USES THEREOF
#24Targeted Delivery of Theranostic Agents
#25ENGINEERED CASCADE COMPONENTS AND CASCADE COMPLEXES
#26OFF-THE-SHELF CANCER VACCINES
#27TYR PEPTIDE COMPOSITIONS AND METHODS FOR USE
#28ANTIMICROBIAL PEPTIDE FOR MAINTAINING HEALTH OF SCALP MICROBIOME AND METHOD FOR PREVENTION OR TREATMENT OF SCALP DISEASE USING THE SAME
#29CELL-REACTIVE, LONG-ACTING, OR TARGETED COMPSTATIN ANALOGS AND USES THEREOF
#30PEPTIDES WITH CYTOKINE-RELEASING ACTIVITY AND METHODS FOR CHARACTERIZING CYTOKINE-RELEASING PROFILES OF PEPTIDES
#31MODIFIED PEPTIDE FRAGMENTS OF CAV-1 PROTEIN AND THE USE THEREOF IN THE TREATMENT OF FIBROSIS
#32COMPOUNDS COMPRISING A FIBROBLAST ACTIVATION PROTEIN LIGAND AND USE THEREOF
#33SELF-ASSEMBLING PEPTIDE SCAFFOLD
#34INSULIN LIKE GROWTH FACTOR BINDING PROTEIN BIOACTIVE PEPTIDE FRAGMENTS
#35METHOD OF TREATMENT OF NEUTROPHIL-DRIVEN INFLAMMATORY PATHOLOGIES
#36CARRIER PEPTIDE FRAGMENT AND USE THEREOF
#37PEPTIDES WITH ANTIMICROBIAL PROPERTIES
#38BIOACTIVE PEPTIDES FOR CONTROLLING INSECTS
#39ANTIMICROBIAL PEPTIDOMIMETICS
#40THERAPEUTIC PEPTIDES AND METHODS OF PEPTIDE DESIGN
#41BRINP2-DERIVED PEPTIDE COMPOSITIONS FOR TREATING OBESITY AND WEIGHT MANAGEMENT
#42PEPTIDE COMPOUNDS TO REGULATE THE COMPLEMENT SYSTEM
#43METHOD FOR PRODUCING FC-CONTAINING MOLECULE MODIFYING REAGENT
#44PEPTIDE OLIGONUCLEOTIDE CONJUGATES
#45CRM197 PROTEIN EXPRESSION METHOD
#46DEVELOPMENT OF PEPTIDES WITH ANTI-CANCER AND ANTIMICROBIAL PROPERTIES
#47NEMO COILED COIL MIMICS AND METHODS OF USING SAME
#48PEPTIDE EXHIBITING ANTIBACTERIAL AND ANTI-INFLAMMATORY ACTIVITIES AND METHOD FOR TREATING MEDICAL CONDITION WITH THE SAME
#49IL-17A BINDING PEPTIDES AND MEDICAL USES THEREOF
#50BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR EPHA2
#51PEPTIDE INHIBITOR AND USE THEREOF
#52CELL-PENETRATING PEPTIDES
#53NOVEL ALPHA-FACTOR BASED PEPTIDES WITH ANTIFUNGAL ACTIVITY
#54Carrier Peptide Fragment and Use Thereof
#55IMMUNOLOGICALLY ACTIVE POLYPEPTIDE
#56PEPTIDES AND MAGNETIC PARTICLE-PEPTIDE CONJUGATES FOR PREVENTION OR TREATMENT OF GLAUCOMA
#57ANTIMICROBIAL PEPTIDES AGAINST CITRUS GREENING
#58SELECTIVE TARGETING OF UBIQUITIN- AND UBIQUITIN-LIKE E1-ACTIVATING ENZYMES BY STRUCTURALLY-STABILIZED PEPTIDES
#59DEFENSIN FRAGMENTS FOR USE IN THERAPY OR PROPHYLAXIS
#60NEW EGFRVIII-BINDING PEPTIDES, CONJUGATES AND USES THEREOF
#61METHOD FOR TREATING OR PREVENTING BRONCHIAL ALLERGIC DISEASES WITH PEPTIDE COMPOSITION
#62PEPTIDE AND PEPTIDE-CONTAINING AGENT
#63MITIGATING TISSUE DAMAGE AND FIBROSIS VIA LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN (LTBP4)
#64SERPIN PEPTIDES AND METHODS OF USING THE SAME
#65PEPTIDE COMPOSITIONS AND METHODS OF USE
#66Engineering Peptides Using Peptide Epitope Linker Evolution
#67USE OF D-ENANTIOMERIC PEPTIDE LIGANDS OF MONOMERIC ALPHA-SYNUCLEIN FOR THE THERAPY OF VARIOUS SYNUCLEINOPATHIES
#68METHOD AND COMPOSITION FOR TREATING NEURODEGENERATIVE DISORDER
#69PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST ACUTE MYELOID LEUKEMIA (AML) AND OTHER HEMATOLOGICAL NEOPLASMS
#70METHODS AND COMPOSITIONS FOR MATURING CARDIOMYOCYTES
#71LIQUID DETERGENT AND UNIT DOSE DETERGENT COMPOSITIONS AND METHODS OF USING THE SAME
#72PEPTIDE-HINGE-FREE FLEXIBLE ANTIBODY-LIKE MOLECULE
#73Binding Domain Mapping and Compounds, Compositions, Complexes, Methods, and Kits Related Thereto
#74DPEP-1 BINDING AGENTS AND METHODS OF USE
#75POLYPEPTIDE INHIBITORS AND USES THEREOF
#76COMPOSITIONS AND METHODS FOR CNS DISEASES
#77Branched Polypeptide Carrier for Efficient Nucleic Acid Delivery and Its Variants
#78GhR-BINDING PEPTIDE AND COMPOSITION COMPRISING SAME
#79AGENTS INDUCING VASCULARISATION
#80PROTEIN-PROTEIN INTERACTION MODULATORS AND METHODS FOR DESIGN THEREOF
#81PEPTIDE ANALOG WITH ANTI-INFLAMMATORY ACTIVITY AND ITS PREPARATION METHOD AND APPLICATION
#82USE OF D-ENANTIOMERIC PEPTIDE LIGANDS OF MONOMERIC TAU FOR THE THERAPY OF VARIOUS TAUOPATHIES
#83ANTI-CANCER LEUCINE-RICH PEPTIDES AND USES THEREOF
#84PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF VISCERAL PAIN
#85MENAQUINONE-BINDING COMPOUNDS AND METHODS OF USE THEREOF
#86COMPOSITION FOR IMPROVING HAIR HEALTH
#87VASCULAR EMBOLIC SYSTEM
#88SWITCHING PEPTIDE AND IMMUNOASSAY USING SAME
#89CONJUGATED HEPCIDIN MIMETICS
#90PEPTIDES FOR INTRACELLULAR DELIVERY
#91SHORT APOLIPOPROTEIN E MIMETIC PEPTIDES AND METHODS OF USE
#92POLYPEPTIDE FOR SPECIFICALLY BLOCKING BINDING OF ACVR1C TO GREM1 AND USE THEREOF
#93ANTIMICROBIAL PEPTIDE AND APPLICATION THEREOF
#94INHIBITION OF PULMONARY FIBROSIS WITH NUTLIN-3A AND PEPTIDES
#95METHODS OF ON DEMAND IN VIVO PHOTOTAGGING
#96NOVEL PEPTIDE, USGAES THEREOF AND PHARMACEUTICAL COMPOSITION HAVING THE SAME
#97PEPTIDES AND NANOPARTICLES FOR INTRACELLULAR DELIVERY OF MOLECULES
#98DRY POWDER FORMULATION OF CAVEOLIN-1 PEPTIDES AND METHODS OF USE THEREOF
#99SEQUENCE FOR PROTEIN DECAY
#100PEPTIDE COMPOUNDS AND PEPTIDE CONJUGATES FOR THE TREATMENT OF CANCER THROUGH RECEPTOR-MEDIATED CHEMOTHERAPY
#101POLYPEPTIDE, PREPARATION METHOD, AND USE THEREOF
#102CELL PENETRATING POLYPEPTIDES (CPPS) AND THEIR USE IN HUMAN THERAPY
#103A SYSTEM AND METHOD FOR COMPARTMENTALIZED INGREDIENTS FOR A LIQUID PHARMACEUTICAL FORMULATION
#104PEPTIDE HAVING ACTIVITY OF IMPROVING STATE OF SKIN, AND USE THEREOF
#105NOVEL ANTIMICROBIAL PEPTIDES AND METHODS OF USE THEREOF
#106PEPTIDE TO TREAT ALPHA-SYNUCLEIN AMYLOID BASED DISORDERS
#107COMPOSITIONS AND METHODS FOR REDUCING ICE CRYSTAL FORMATION
#108CELL-REACTIVE, LONG-ACTING, OR TARGETED COMPSTATIN ANALOGS AND RELATED COMPOSITIONS AND METHODS
#109SYNTHETIC ANTIMICROBIAL PEPTIDES
#110COMPOSITIONS AND METHODS FOR ANTI-PHOSPHOCHOLINE ACTIVE IMMUNOTHERAPY
#111COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING METABOLIC DISORDERS
#112PEPTIDE DERIVATIVES AND RELATED USES AS OREXIN AGONISTS
#113PEPTIDES FOR PROMOTING HAIR FOLLICLE NEOGENESIS, AND PREVENTION/MITIGATION OF UNTOWARD EFFECTS OF RADIATION TREATMENT
#114BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR TRANSFERRIN RECEPTOR 1 (TfR1)
#115ANTIBODY SPECIFIC CAPTURE AGENTS, COMPOSITIONS, AND METHODS OF USING AND MAKING
#116NOVEL ANTIMICROBIAL PEPTIDE WITH EXCELLENT MICROBIAL CYTOPLASM ELUTION EFFECT
#117PROBES AND KITS FOR THE EARLY DIAGNOSIS OF DIFUSE LARGE B-CELL LYMPHOMA
#118METHODS OF USING SELECTIVE DELIVERY MOLECULES
#119CELLULAR UPTAKE OF LARGE BIOMOLECULES ENABLED BY CELL-SURFACE-REACTIVE CELL-PENETRATING PEPTIDE ADDITIVES
#120HETERODIMERIC PEPTIDE REAGENTS AND METHODS
#121BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR NECTIN-4
#122POLYPEPTIDE FOR REPAIRING SKIN WOUND OR MUCOSAL INJURY, AND APPLICATION THEREOF
#123BROAD-SPECTRUM ANTIVIRAL DRUG FOR ENTEROVIRUS, AND APPLICATION
#124Construct for Transferring Foreign Substance, and Use Thereof
#125POLYPEPTIDES AND METHODS FOR IMPROVING SKIN CONDITIONS
#126PEPTIDES AND NANOPARTICLES FOR INTRACELLULAR DELIVERY OF GENOME-EDITING MOLECULES
#127BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR MT1-MMP
#128ONCOLYTIC PEPTIDE AND USE THEREOF
#129ANTIMICROBIAL PEPTIDE DERIVATIVE AND USE THEREOF
#130DISRUPTION OF SONIC HEDGEHOG-SURF4 INTERACTION FOR CANCER TREATMENT
#131PEPTIDE LIGANDS FOR BINDING TO MT1-MMP
#132COMPOSITION FOR ENHANCING ACTIVITY OF NATURAL KILLER CELLS
#133PLATFORM DRUG DELIVERY SYSTEM UTILIZING CRYSTAL ENGINEERING AND THEANINE DISSOLUTION
#134ENGINEERING OF MULTIFUNCTIONAL PEPTIDES FOR CONTROLLED DRUG DELIVERY
#135LYSINE RICH CELL-PENETRATING PEPTIDES
#136Transmembrane Allosteric Short Peptides Modulating Human Mu-Opioid Receptor for Analgesic Effects and Covalent Steroid Modifications of Transmembrane Allosteric Peptides for Enhanced Mu-Opioid Receptor Interaction in Chronic Pain Therapies
#137COMPOSITIONS AND METHOD FOR OPTIMIZED PEPTIDE VACCINES USING RESIDUE OPTIMIZATION
#138BIFUNCTIONAL PEPTIDES FOR BIOMIMETIC RECONSTRUCTION OF SILVER DIAMINE FLUORIDE TREATED DENTAL TISSUES
#139COMPOSITIONS AND METHODS FOR THE TREATMENT OF NEURODAMAGE
#140Rodenticide
#141COMPOSITION COMPRISING TAT PEPTIDE VARIANT AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING METABOLIC DISEASES
#142PEPTIDE HAVING ANTI-AGING ACTIVITY, AND USE THEREOF
#143COMPOSITIONS TARGETING EPIDERMAL GROWTH FACTOR RECEPTOR AND METHODS FOR MAKING AND USING THE SAME
#144EXON SKIPPING OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPHY
#145METHODS AND SYSTEMS FOR DESIGNING AND/OR CHARACTERIZING SOLUBLE LIPIDATED LIGAND AGENTS
#146Alpha-sheet Polypeptides and Their Use
#147PROTEIN INTERFACES
#148PHOTORESPONSIVE PEPTIDE DELIVERY SYSTEM AND METHOD OF USING THE SAME
#149MONOCLONAL ANTIBODIES FOR DETECTING KAWASAKI DISEASE ANTIGENS
#150ULTRA-PURE AGONISTS OF GUANYLATE CYCLASE C, METHOD OF MAKING AND USING SAME
#151DOSING REGIMENS AND RELATED COMPOSITIONS AND METHODS
#152BCL-W Polypeptides and Mimetics for Treating or Preventing Chemotherapy-Induced Peripheral Neuropathy and Hearing Loss
#153PEPTIDES TARGETING THE INTERACTION BETWEEN KINDLIN-1 AND Beta-INTEGRIN
#154THERAPEUTIC AGENTS FOR REDUCING PARATHYROID HORMONE LEVELS
#155PEPTIDES FOR TREATING PAIN OR REDUCING PAIN SENSITIVITY
#156PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR
#157INHIBITION OF TREM RECEPTOR SIGNALING WITH PEPTIDE VARIANTS
#158METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE
#159PHOSPHORYLATED AKT-SPECIFIC CAPTURE AGENTS, COMPOSITIONS, AND METHODS OF USING AND MAKING
#160PEPTIDE COMPOUNDS TO REGULATE THE COMPLEMENT SYSTEM
#161BIOMIMETIC PEPTIDES AND THEIR USE IN BONE REGENERATION
#162PEPTIDE, AND CELL FUSION AGENT AND PHARMACEUTICAL COMPOSITION FOR CANCER THERAPY CONTAINING SAID PEPTIDE
#163POLYPEPTIDE, PRODUCT INCLUDING POLYPEPTIDE FOR INHIBITING FUSOBACTERIUM NUCLEATUM, OR DRUG FOR PREVENTING COLORECTAL CANCER
#164MELANOCORTIN 1 RECEPTOR LIGANDS AND METHODS OF USE
#165IMMUNE CHECKPOINT TARGETING THERAPEUTIC NANOPARTICLES
#166NOVEL METHOD FOR PROMOTING NODULATION IN PLANTS
#167LABEL-FREE DETECTION OF PROTEASE ACTIVITY
#168PEPTIDE HAVING ANTIBACTERIAL, ANTI-INFLAMMATORY OR TISSUE REGENERATION ABILITY AND USE THEREOF
#169STAPLED PEPTIDES AS PYRIN-DOMAIN TARGETED NLRP3 INFLAMMASOME INHIBITORS
#170NEUROPROTECTIVE POLYPEPTIDE COMPOUND AND APPLICATION THEREOF
#171VISTA ANTAGONIST AND METHODS OF USE
#172MITIGATING TISSUE DAMAGE AND FIBROSIS VIA LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN (LTBP4)
#173PEPTIDE USEFUL FOR THE TRANSPORT OF MOLECULES THROUGH CELL BARRIERS
#174POLYPEPTIDE AND USE THEREOF IN REGULATING BLOOD GLUCOSE LEVEL AND/OR REDUCING FAT
#175POLYPEPTIDE COMPOUND AND USE THEREOF IN TREATMENT OF ENTERITIS
#176USE OF AMINO ACID SEQUENCES FROM MYCOBACTERIUM TUBERCULOSIS OR CORRESPONDING NUCLEIC ACIDS FOR DIAGNOSIS AND PREVENTION OF TUBERCULAR INFECTION, DIAGNOSTIC KIT AND VACCINE THEREFROM
#177ANTICANCER PEPTIDE AND USE IN TREATING CANCER
#178Peptides for the Treatment of Retinitis Pigmentosa
#179ANTIBODY/DRUG CONJUGATES AND METHODS OF USE
#180RESPIRATORY SYNCYTIAL VIRUS F PROTEINS AND NANOSTRUCTURES AND USES THEREOF
#181CELL CULTURE SCAFFOLD, AND PREPARATION METHOD THEREOF
#182PEPTIDE AND COMPOSITION
#183Genetically Reprogrammed Extracellular Matrix
#184ANTIMICROBIAL PEPTIDES AND METHODS OF USING SAME
#185USE OF SE-DR AFFINITY PEPTIDE IN PREPARING DRUG FOR TREATING RHEUMATIC DISEASE
#186DLL3 BINDING PEPTIDES AND USES THEREOF
#187CD44-BINDING PEPTIDE REAGENTS AND METHODS
#188NOVEL SKIN-PERMEABLE PEPTIDE, COMPOSITION INCLUDING THE SAME FOR SKIN AND MUCOUS MEMBRANE, AND USE THEREOF
#189IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING LUNG CANCER
#190BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR NECTIN-4
#191PD-L1 INHIBITORY PEPTIDE FOR CANCER IMMUNOTHERAPY
#192CYSTEINE PEPTIDE-ENABLED ANTIBODIES
#193FUSION PROTEINS AND METHODS FOR MONITORING FIBRONECTIN MATRIX ASSEMBLY
#194CELL-SURFACE ENGINEERING COMPOSITIONS AND METHODS FOR THE PREVENTION OF IMMUNE REJECTION
#195ERYTHROCYTE-BINDING THERAPEUTICS
#196VARIABLE LYMPHOCYTE RECEPTORS THAT TARGET THE BRAIN EXTRACELLULAR MATRIX AND METHODS OF USE
#197PEPTIDE HAVING ACTIVITY OF IMPROVING STATE OF SKIN, AND USE THEREOF
#198PEPTIDES AND T CELLS FOR USE IN IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS CANCERS
#199BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR NECTIN-4
#200PEPTIDE INHIBITORS AND METHODS FOR INHIBITING PROTEIN AGGREGATION IN NEURONS AND NEURODEGENERATIVE DISEASES
#201FORMULATIONS OF GUANYLATE CYCLSE C AGONISTS AND METHODS OF USE
#202PEPTIDE LIBRARY AND USE THEREOF
#203Biological Production of Histidine-Rich Peptides
#20414-3-3 TARGETING PEPTIDES FOR CANCER TREATMENT
#205COLLAGEN TYPE III COMPOSITION PREPARED FROM FIBROBLAST EXTRACELLULAR MATRIX
#206COMPOSITIONS FOR PREVENTING OR TREATING INFLUENZA INFECTIONS
#207PEPTIDES AND PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM
#208PEPTIDES AND PEPTIDE CONJUGATES FOR TREATING MENTAL DISORDERS
#209PEPTIDE HAVING INHIBITORY ACTIVITY AGAINST AMYLOID PRECURSOR PROTEIN AND USE THEREOF
#210PEPTIDES FOR THE TREATMENT OF CHRONICALLY ACTIVE AUTOIMMUNE INFLAMMATION
#211ACTIVATION OF BIOLUMINESCENCE BY STRUCTURAL COMPLEMENTATION
#212CLEAVABLE LINKER COMPOSITIONS AND METHODS
#213PHARMACOKINETICS AND CHOLECYSTOKININ-2 RECEPTOR (CCK2R) TARGETING FOR DIAGNOSIS AND THERAPY
#214ANTIMICROBIAL PEPTIDE BOLESPLEENIN OF BOLEOPHTHALMUS PECTINIROSTRIS AND APPLICATION THEREOF
#215TARGETED/IMMUNOMODULATORY FUSION PROTEINS AND METHODS FOR MAKING SAME
#216TUMOR TISSUE-PENETRATING PEPTIDE, SPECIFICALLY BINDING TO NEUROPILIN 1, FOR DRUG DELIVERY TO TUMOR, AND USE THEREOF
#217FILMS FORMED FROM SELF-ASSEMBLING PEPTIDE HYDROGELS
#218METHODS AND COMPOSITIONS FOR VISUALIZING A URETER IN A SURGICAL PROCEDURE
#219BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR NECTIN-4
#220PEPTIDE HYDROGEL COMPRISING HYDROPHILIC AZIDE-CONTAINING AMINO ACID AND ITS USE
#221PEPTIDE COMPOSITIONS CAPABLE OF BINDING LANTHIONINE SYNTHETASE C-LIKE PROTEIN (LANCL) AND USES THEREOF
#222A NOVEL PEPTIDE AND THE USE THEREOF
#223NUCLEIC ACID MOLECULES, FUSION PROTEINS, AND MRNA VACCINES WITH ENHANCED ANTIGEN PRESENTATION BY RECRUITING LIGANDS
#224MESOPOROUS SILICA BINDING PEPTIDES AND METHODS OF ENZYME IMMOBILIZATION USING THE SAME
#225MECHANICALLY INTERLOCKING COMPLEXES
#226PEPTIDE HAVING INDEPENDENTLY STABILIZED HYDROPHOBIC ALPHA HELIX, PEPTIDE COMPLEX COMPRISING SAME AND USES THEREOF
#227POLYPEPTIDE FOR INHIBITING TRPM8 AND USE THEREOF
#228PEPTIDE HAVING ANTI-AGING ACTIVITY, AND USE THEREOF
#229ANTAGONIST FUSION POLYPEPTIDES
#230PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST HEPATOCELLULAR CARCINOMA (HCC) AND OTHER CANCERS
#231PEPTIDE HAVING ANTI-AGING ACTIVITY, AND USE THEREOF
#232COMPOSITIONS TARGETING EPIDERMAL GROWTH FACTOR RECEPTOR AND METHODS FOR MAKING AND USING THE SAME
#233BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR NECTIN-4
#234PEPTIDE FOR PENETRATING BLOOD-BRAIN BARRIER AND USE THEREOF
#235ENGINEERING AAV
#236TRANSFECTION COMPLEXES AND METHODS OF USING THE SAME
#237BIOMIMETIC PEPTIDE AND BIODEGRADABLE DELIVERY PLATFORM FOR THE TREATMENT OF ANGIOGENESIS- AND LYMPHANGIOGENESIS-DEPENDENT DISEASES
#238STAPLED PEPTIDES AND METHODS THEREOF
#239PEPTIDE FOR DETECTING CA125 AND USE THEREOF
#240NOVEL NANOMATERIALS FROM NANOG PRION-LIKE REPEATS
#241Substrate-specific adhesive peptides
#242CNP CYCLIC PEPTIDE, AND MEDICINE, EXTERNAL PREPARATION AND COSMETIC EACH CONTAINING SAID CYCLIC PEPTIDE
#243PEPTIDES THAT BIND TO TEXTILES
#244STAPLED PEPTIDES AND METHODS THEREOF
#245Biological active peptide for improving enzyme activity of ACE2 and application thereof
#246EPITHELIAL SODIUM CHANNEL (ENAC) INHIBITOR CONJUGATES AND METHODS FOR USE THEREOF
#247SITE-SPECIFIC RADIOISOTOPE-LABELED ANTIBODY USING IgG-BINDING PEPTIDE
#248PEPTIDE HAVING BLOOD COAGULATION ACTIVITY, AND USE THEREOF
#249IMMUNOGENIC WT-1 PEPTIDES AND METHODS OF USE THEREOF
#250STERILIZATION OF SELF-ASSEMBLING PEPTIDES BY IRRADIATION
#251PEPTIDES WITH ANTIMICROBIAL ACTIVITIES
#252METHODS FOR TREATMENT AND DIAGNOSIS OF NON-ALCOHOLIC STEATOHEPATITIS AND/OR HEPATOCELLULAR CARCINOMA
#253PEPTIDE DERIVATIVES AND RELATED USES AS OREXIN AGONISTS
#254Nanoparticles and Peptides for the Delivery of Cargos to Muscle Cells
#255MASKED CHIMERIC ANTIGEN RECEPTOR SPECIFIC TO TYROSINE-PROTEIN KINASE LIKE 7 (PTK7) AND IMMUNE CELLS EXPRESSING SUCH
#256PEPTIDE AND GELATIN HYBRID HYDROGELS AS ECONOMICAL ALTERNATIVES TO COMMON BASEMENT-MEMBRANE MATRICES
#257NOVEL COMPOSITIONS AND METHODS FOR TREATING CORONAVIRUS INFECTIONS
#258NOVEL PEPTIDES & COMBINATION OF PEPTIDES AS TARGETS OR ACTIVE INGREDIENTS FOR USE IN IMMUNOTHERAPY AGAINST AML & OTHER CANCERS
#259STAPLED INTRACELLULAR-TARGETING ANTIMICROBIAL PEPTIDES TO TREAT INFECTION
#260CELL-PENETRATING PEPTIDE, ANTI-CANCER PEPTIDE, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER, COMPRISING SAME
#261HETEROTANDEM BICYCLIC PEPTIDE COMPLEX
#262AMPHIPHILIC PEPTIDES FOR NUCLEIC ACID AND PROTEIN DELIVERY
#263ANTIMICROBIAL PEPTIDOMIMETICS
#264PEPTIDE COMPOUND TARGETING ELASTIN-DERIVED PEPTIDES AND USE THEREOF
#265SHORT PEPTIDES, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME, AND USES THEREOF IN TREATING NEUROLOGICAL DISEASES
#266APELIN POLYPEPTIDES
#267NORA INHIBITORS AND METHODS OF USE
#268PEPTIDE FRAGMENTS FOR TREATMENT OF DIABETES
#269POST-PROCESSING OF BIOLOGICAL SCAFFOLDS
#270TOPICAL PEPTIDE FORMULATION FOR THE TREATMENT OF SEXUAL DYSFUNCTION
#271WAFER LEVEL CHIP SCALE PACKAGE WITH RHOMBUS SHAPE
#272REGULATORY T CELL EPITOPES
#273PEPTIDE HAVING ANTI-VIRAL ACTIVITY, ANTI-VIRAL AGENT COMPRISING SAID PEPTIDE, AND METHOD FOR PRODUCING SAID ANTI-VIRAL AGENT
#274PEPTIDE COMPOUNDS TO REGULATE THE COMPLEMENT SYSTEM
#275COMPSTATIN ANALOGUES AND THEIR MEDICAL USES
#276NLRP3 INFLAMMASOME INHIBITORY PEPTIDE FOR TREATMENT OF INFLAMMATORY DISEASES
#277MICROPEPTIDES AND USE OF SAME FOR MODULATING GENE EXPRESSION
#278PLASMIN-RESISTANT PEPTIDES FOR IMPROVED THERAPEUTIC INDEX
#279NOVEL PEPTIDES AND USES THEREOF FOR TREATING CANCER
#280MHC CLASS II T-CELL MODULATORY MULTIMERIC POLYPEPTIDES FOR TREATING TYPE 1 DIABETES MELLITUS (T1D) AND METHODS OF USE THEREOF
#281METHODS FOR DETECTING PEPTIDE/MHC/TCR BINDING
#282STABILIZED PEPTIDES FOR COVALENT BINDING TO TARGET PROTEIN
#283CONSTRAINED PEPTIDES
#284Antimicrobial Peptides
#285ANALGESIC AND ANESTHETIC PEPTIDES AND OTHER AGENTS
#286PROCASPASE-CLEAVING PROTEASES AND USES THEREOF
#287MITIGATING TISSUE DAMAGE AND FIBROSIS VIA LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN (LTBP4)
#288Ultra-pure agonists of guanylate cyclase C, method of making and using same
#289PHARMACEUTICAL COMPOSITION AND THE USE THEREOF IN THE TREATMENT OF AUTOIMMUNE DISEASES
#290ANTIMICROBIAL PEPTIDE OR PEPTIDE DERIVATIVE, SUBSTITUTE, AND COMPOSITION THEREOF, AND PREPARATION METHOD AND APPLICATION OF COMPOSITION
#291PEPTIDES FOR USE AS SENOTHERAPEUTIC AGENTS
#292PEPTIDE, COMPOSITION, AND GHRELIN SECRETION PROMOTING AGENT
#293DOSING REGIMENS AND RELATED COMPOSITIONS AND METHODS
#294NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CLL AND OTHER CANCERS
#295DOSING REGIMENS
#296ERYTHROCYTE-BINDING THERAPEUTICS
#297COMPOUNDS FOR USE AS APELIN RECEPTOR ANTAGONISTS
#298ANTI-HEPATITIS B VIRUS AGENT TARGETING HOST FACTOR LIPG
#299SELECTIVE PENICILLAMINE SUBSTITUTION ENABLES DEVELOPMENT OF A POTENT ANALGESIC PEPTIDE THAT ACTS THROUGH A NON-OPIOID BASED MECHANISM
#300Dry powder formulation of caveolin-1 peptides and methods of use thereof